Recce Pharmaceuticals Ltd.ASX: RCE

Key Opinion Leader Presentation

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 38 pages · English

Summary by 6ix AI

The presentation outlines the successful outcomes of a Phase II clinical trial, which achieved all primary and secondary endpoints, demonstrating the gel's safety and efficacy. Additionally, the company is preparing for a Phase III trial in Indonesia, which has been approved to further evaluate the gel's effectiveness in a larger patient population.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

In the deck

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases